Development of medicines and vaccines against covid-19
In the EU, four vaccines are currently approved. The global medicine authorities are all in close dialogue with researchers and pharmaceutical companies that want to develop medicines, including vaccines, for covid-19. This also applies to the European Medicines Agency (EMA), to which Norway is affiliated.
Only diagnostic tests, face masks and other medical devices with the CE mark are approved for safe use. A number of diagnostic tests may not be used by persons without health-related qualifications. Tests that can detect covid-19 or other illnesses should always be marked with information about who is authorised to use the device.
The Norwegian Medicines Agency will give priority to applications for clinical trials that have a direct impact on the pandemic. Nonetheless, we expect reports to satisfy the normal requirements. Please send all enquiries to firstname.lastname@example.org.
The Norwegian health authorities have introduced rationing of vital medicines in order to ensure fair distribution of medicines to prevent stockpiling.
See more information in Norwegian.
Safe use of medicines
Talk to a doctor about correct use of medicines if you have contracted covid-19 or are afraid of contracting it. At the time of writing, there are no approved medicines for use to treat covid-19 outside a hospital setting. Any websites offering medicines for covid-19 are fraudulent.
- Do not take any medicines to treat covid-19 without talking to a doctor first.
- Do not use medicines for other conditions to treat covid-19 without talking to a doctor first. This applies to both prescription medicines and products that can be purchased over the counter.
Only purchase medicines from Norwegian pharmacies or online pharmacies that have been approved by the healt authorities. For a list of approved online pharmacies in Norway, click here.
Export of medicines requires approval from the Norwegian Medicines Agency
Wholesalers must submit an application to the Norwegian Medicines Agency before they are permitted to export medicines out of Norway. The Norwegian Medicines Agency requires three days to process the application before granting export of medicines.
The Norwegian Medicines Agency is authorised to prohibit parallel export of medicines in situations where there is reason to believe that this will result in a lack of access to medicines in Norway. See more information in Norwegian.
Emergency stocks of medicines
The health authorities have signed agreements with the three largest pharmaceutical wholesalers regarding extension of their stocks, and have requested that they purchase medicines that are critical for the public health service. See more information in Norwegian.
Important medicines required to support patients being treated for covid-19
The Norwegian Medicines Agency, in cooperation with clinical experts, has prepared a list of medicines that may be required to treat covid-19 patients, and which we expect to be in increased demand. See more information in Norwegian.
Prescribing medicines for animals during the pandemic
During the pandemic, there is an extra high risk of lack of important medicines for humans. If a veterinarian has prescribed/ordered important medicines for humans, the Norwegian Medicines Agency is authorised to request or order that the pharmacy deliver a corresponding, marketed veterinarian medicine, where this exists. The Norwegian Medicines Agency will exercise this authority when necessary to reserve the medicines in question for human use.